T3 blood levels and treatment outcome in depression

Dan V. Iosifescu, Shauna Howarth, Jonathan E. Alpert, Andrew A. Nierenberg, John J. Worthington, Maurizio Fava

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective: We examined the correlation between the basal triiodothyronine resin uptake (T3-RU) levels in depressed subjects and the response to antidepressant treatment. Method: We treated with fluoxetine 235 outpatients meeting DSM-IV criteria for major depression. We measured T3 resin uptake (T3-RU) levels before the onset of treatment. The 17-item Hamilton Rating Scale for Depression (Ham-D-17) was administered before, during and after the eight weeks of treatment to assess changes in depressive symptoms. Results: 16 patients (6.8 percent) had low T3-RU levels (range 16.5-21), and 7 patients (3.0 percent) had high T3-RU levels (range 36-38). No relationship was found between T3-RU levels and clinical improvement, defined as either total Ham-D- 17 score change or Ham-D- 17 score ≤ 7 in the last 3 weeks of treatment, even after adjusting for baseline severity of depression. Conclusion: Abnormal T3-RU levels are rather uncommon in outpatient depression and do not correlate with the response to antidepressant treatment or lack thereof.

Original languageEnglish (US)
Pages (from-to)367-373
Number of pages7
JournalInternational Journal of Psychiatry in Medicine
Volume31
Issue number4
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Depression
Antidepressive Agents
Outpatients
Therapeutics
Fluoxetine
Triiodothyronine
Diagnostic and Statistical Manual of Mental Disorders

Keywords

  • Antidepressant
  • Major depression
  • T-RU
  • Thyroid hormones
  • Treatment response
  • Triiodothyronine

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Iosifescu, D. V., Howarth, S., Alpert, J. E., Nierenberg, A. A., Worthington, J. J., & Fava, M. (2001). T3 blood levels and treatment outcome in depression. International Journal of Psychiatry in Medicine, 31(4), 367-373. https://doi.org/10.2190/6FK8-DBGL-MWR1-MV58

T3 blood levels and treatment outcome in depression. / Iosifescu, Dan V.; Howarth, Shauna; Alpert, Jonathan E.; Nierenberg, Andrew A.; Worthington, John J.; Fava, Maurizio.

In: International Journal of Psychiatry in Medicine, Vol. 31, No. 4, 2001, p. 367-373.

Research output: Contribution to journalArticle

Iosifescu, DV, Howarth, S, Alpert, JE, Nierenberg, AA, Worthington, JJ & Fava, M 2001, 'T3 blood levels and treatment outcome in depression', International Journal of Psychiatry in Medicine, vol. 31, no. 4, pp. 367-373. https://doi.org/10.2190/6FK8-DBGL-MWR1-MV58
Iosifescu, Dan V. ; Howarth, Shauna ; Alpert, Jonathan E. ; Nierenberg, Andrew A. ; Worthington, John J. ; Fava, Maurizio. / T3 blood levels and treatment outcome in depression. In: International Journal of Psychiatry in Medicine. 2001 ; Vol. 31, No. 4. pp. 367-373.
@article{f3ab1d0fef2c49308d625f33b5c32cc2,
title = "T3 blood levels and treatment outcome in depression",
abstract = "Objective: We examined the correlation between the basal triiodothyronine resin uptake (T3-RU) levels in depressed subjects and the response to antidepressant treatment. Method: We treated with fluoxetine 235 outpatients meeting DSM-IV criteria for major depression. We measured T3 resin uptake (T3-RU) levels before the onset of treatment. The 17-item Hamilton Rating Scale for Depression (Ham-D-17) was administered before, during and after the eight weeks of treatment to assess changes in depressive symptoms. Results: 16 patients (6.8 percent) had low T3-RU levels (range 16.5-21), and 7 patients (3.0 percent) had high T3-RU levels (range 36-38). No relationship was found between T3-RU levels and clinical improvement, defined as either total Ham-D- 17 score change or Ham-D- 17 score ≤ 7 in the last 3 weeks of treatment, even after adjusting for baseline severity of depression. Conclusion: Abnormal T3-RU levels are rather uncommon in outpatient depression and do not correlate with the response to antidepressant treatment or lack thereof.",
keywords = "Antidepressant, Major depression, T-RU, Thyroid hormones, Treatment response, Triiodothyronine",
author = "Iosifescu, {Dan V.} and Shauna Howarth and Alpert, {Jonathan E.} and Nierenberg, {Andrew A.} and Worthington, {John J.} and Maurizio Fava",
year = "2001",
doi = "10.2190/6FK8-DBGL-MWR1-MV58",
language = "English (US)",
volume = "31",
pages = "367--373",
journal = "International Journal of Psychiatry in Medicine",
issn = "0091-2174",
publisher = "Baywood Publishing Co. Inc.",
number = "4",

}

TY - JOUR

T1 - T3 blood levels and treatment outcome in depression

AU - Iosifescu, Dan V.

AU - Howarth, Shauna

AU - Alpert, Jonathan E.

AU - Nierenberg, Andrew A.

AU - Worthington, John J.

AU - Fava, Maurizio

PY - 2001

Y1 - 2001

N2 - Objective: We examined the correlation between the basal triiodothyronine resin uptake (T3-RU) levels in depressed subjects and the response to antidepressant treatment. Method: We treated with fluoxetine 235 outpatients meeting DSM-IV criteria for major depression. We measured T3 resin uptake (T3-RU) levels before the onset of treatment. The 17-item Hamilton Rating Scale for Depression (Ham-D-17) was administered before, during and after the eight weeks of treatment to assess changes in depressive symptoms. Results: 16 patients (6.8 percent) had low T3-RU levels (range 16.5-21), and 7 patients (3.0 percent) had high T3-RU levels (range 36-38). No relationship was found between T3-RU levels and clinical improvement, defined as either total Ham-D- 17 score change or Ham-D- 17 score ≤ 7 in the last 3 weeks of treatment, even after adjusting for baseline severity of depression. Conclusion: Abnormal T3-RU levels are rather uncommon in outpatient depression and do not correlate with the response to antidepressant treatment or lack thereof.

AB - Objective: We examined the correlation between the basal triiodothyronine resin uptake (T3-RU) levels in depressed subjects and the response to antidepressant treatment. Method: We treated with fluoxetine 235 outpatients meeting DSM-IV criteria for major depression. We measured T3 resin uptake (T3-RU) levels before the onset of treatment. The 17-item Hamilton Rating Scale for Depression (Ham-D-17) was administered before, during and after the eight weeks of treatment to assess changes in depressive symptoms. Results: 16 patients (6.8 percent) had low T3-RU levels (range 16.5-21), and 7 patients (3.0 percent) had high T3-RU levels (range 36-38). No relationship was found between T3-RU levels and clinical improvement, defined as either total Ham-D- 17 score change or Ham-D- 17 score ≤ 7 in the last 3 weeks of treatment, even after adjusting for baseline severity of depression. Conclusion: Abnormal T3-RU levels are rather uncommon in outpatient depression and do not correlate with the response to antidepressant treatment or lack thereof.

KW - Antidepressant

KW - Major depression

KW - T-RU

KW - Thyroid hormones

KW - Treatment response

KW - Triiodothyronine

UR - http://www.scopus.com/inward/record.url?scp=0035727709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035727709&partnerID=8YFLogxK

U2 - 10.2190/6FK8-DBGL-MWR1-MV58

DO - 10.2190/6FK8-DBGL-MWR1-MV58

M3 - Article

VL - 31

SP - 367

EP - 373

JO - International Journal of Psychiatry in Medicine

JF - International Journal of Psychiatry in Medicine

SN - 0091-2174

IS - 4

ER -